Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael R Preusch

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Drug Design, Development and Therapy|September 13, 2016
Ticagrelor promotes atherosclerotic plaque stability in a mouse model of advanced atherosclerosisMichael R Preusch, Jonas Rusnak, Kathrin Staudacher, et al.
Drug Design, Development and Therapy|September 23, 2015
Dabigatran etexilate retards the initiation and progression of atherosclerotic lesions and inhibits the expression of oncostatin M in apolipoprotein E-deficient miceMichael R Preusch, Nicholas Ieronimakis, Errol S Wijelath, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|October 3, 2025
The orphan receptor GPRC5B promotes macrophage infiltration and an inflammatory plaque phenotype in atherosclerosisGreta Verena Freundt, Friedrich Alexander von Samson-Himmelstjerna, Jan-Thorge Nitz, et al.
Journal of Cardiovascular Pharmacology|August 19, 2007
Long-term administration of 3-deazaadenosine does not alter progression of advanced atherosclerotic lesions in apolipoprotein E-deficient miceMichael R Preusch, Florian Bea, Sara H Yang, et al.
Mediators of Inflammation|July 24, 2010
Rhizoma Coptidis inhibits LPS-induced MCP-1/CCL2 production in murine macrophages via an AP-1 and NFkappaB-dependent pathwayAndrew Remppis, Florian Bea, Henry Johannes Greten, et al.
International Journal of Molecular Sciences|March 11, 2023
Effect of SARS-CoV-2 mRNA-Vaccine on the Induction of Myocarditis in Different Murine Animal ModelsVanessa A Zirkenbach, Rebecca M Ignatz, Renate Öttl, et al.
European Heart Journal. Acute Cardiovascular Care|March 21, 2023
Mid-regional pro-adrenomedullin and lactate levels for risk stratification in patients with out-of-hospital cardiac arrestThomas A Zelniker, Dominik Schwall, Fardin Hamidi, et al.
Resuscitation|December 15, 2015
Fibroblast growth factor 23 (FGF-23) is an early predictor of mortality in patients with cardiac arrestSebastian Spaich, Thomas Zelniker, Philipp Endres, et al.
European Journal of Clinical Investigation|March 23, 2011
Deletion of bone marrow-derived receptor for advanced glycation end products inhibits atherosclerotic plaque progressionSamuel Morris-Rosenfeld, Erwin Blessing, Michael R Preusch, et al.
Plos One|February 19, 2021
Validation of two severity scores as predictors for outcome in Coronavirus Disease 2019 (COVID-19)Christian Salbach, Matthias Mueller-Hennessen, Moritz Biener, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Drug Design, Development and Therapy|September 13, 2016
Ticagrelor promotes atherosclerotic plaque stability in a mouse model of advanced atherosclerosisMichael R Preusch, Jonas Rusnak, Kathrin Staudacher, et al.
Drug Design, Development and Therapy|September 23, 2015
Dabigatran etexilate retards the initiation and progression of atherosclerotic lesions and inhibits the expression of oncostatin M in apolipoprotein E-deficient miceMichael R Preusch, Nicholas Ieronimakis, Errol S Wijelath, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|October 3, 2025
The orphan receptor GPRC5B promotes macrophage infiltration and an inflammatory plaque phenotype in atherosclerosisGreta Verena Freundt, Friedrich Alexander von Samson-Himmelstjerna, Jan-Thorge Nitz, et al.
Journal of Cardiovascular Pharmacology|August 19, 2007
Long-term administration of 3-deazaadenosine does not alter progression of advanced atherosclerotic lesions in apolipoprotein E-deficient miceMichael R Preusch, Florian Bea, Sara H Yang, et al.
Mediators of Inflammation|July 24, 2010
Rhizoma Coptidis inhibits LPS-induced MCP-1/CCL2 production in murine macrophages via an AP-1 and NFkappaB-dependent pathwayAndrew Remppis, Florian Bea, Henry Johannes Greten, et al.
International Journal of Molecular Sciences|March 11, 2023
Effect of SARS-CoV-2 mRNA-Vaccine on the Induction of Myocarditis in Different Murine Animal ModelsVanessa A Zirkenbach, Rebecca M Ignatz, Renate Öttl, et al.
European Heart Journal. Acute Cardiovascular Care|March 21, 2023
Mid-regional pro-adrenomedullin and lactate levels for risk stratification in patients with out-of-hospital cardiac arrestThomas A Zelniker, Dominik Schwall, Fardin Hamidi, et al.
Resuscitation|December 15, 2015
Fibroblast growth factor 23 (FGF-23) is an early predictor of mortality in patients with cardiac arrestSebastian Spaich, Thomas Zelniker, Philipp Endres, et al.
European Journal of Clinical Investigation|March 23, 2011
Deletion of bone marrow-derived receptor for advanced glycation end products inhibits atherosclerotic plaque progressionSamuel Morris-Rosenfeld, Erwin Blessing, Michael R Preusch, et al.
Plos One|February 19, 2021
Validation of two severity scores as predictors for outcome in Coronavirus Disease 2019 (COVID-19)Christian Salbach, Matthias Mueller-Hennessen, Moritz Biener, et al.
Pageof 5